Aspen Pharmacare
(OTC) APNHF
Aspen Pharmacare Financials at a Glance
Market Cap
$3.86B
Revenue (TTM)
ZAR 83.89B
Net Income (TTM)
ZAR 1.42B
EPS (TTM)
-$0.23
P/E Ratio
-37.08
Dividend
$0.12
Beta (Volatility)
0.12 (Low)
Dividend
$0.12
Beta (Volatility)
0.12 (Low)
Price
$8.70
Volume
4
Open
$8.70
Price
$8.70
Volume
4
Open
$8.70
Previous Close
$8.70
Daily Range
$8.70 - $8.70
52-Week Range
$6.23 - $8.70
Estimated Earnings Date
Sep 2, 2026
Dividend
$0.12
Beta (Volatility)
0.12 (Low)
Price
$8.70
Volume
4
Open
$8.70
Previous Close
$8.70
Daily Range
$8.70 - $8.70
52-Week Range
$6.23 - $8.70
Estimated Earnings Date
Sep 2, 2026
APNHF News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Aspen Pharmacare
Industry
Pharmaceuticals
Sector
Health CareEmployees
9,557
CEO
Stephen Bradley Saad, PhD
Website
www.aspenpharma.comHeadquarters
Durban, ZA
APNHF Financials
Key Financial Metrics (TTM)
Gross Margin
41.91%
Operating Margin
16.01%
Net Income Margin
-5.19%
Return on Equity
-2.41%
Return on Capital
1.19%
Return on Assets
-1.56%
Earnings Yield
-2.70%
Dividend Yield
1.41%
Payout Ratio
-47.07%
Stock Overview
Market Cap
$3.86B
Shares Outstanding
444.02M
Volume
4
Avg. Volume
198.619
Financials (TTM)
Gross Profit
ZAR 36.63B
Operating Income
ZAR 9.65B
EBITDA
ZAR 12.57B
Operating Cash Flow
ZAR 12.43B
Capital Expenditure
-ZAR 5.32B
Free Cash Flow
ZAR 7.13B
Cash & ST Invst.
ZAR 5.58B
Total Debt
ZAR 32.72B
Aspen Pharmacare Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
ZAR 16.96B
-19.1%
Gross Profit
ZAR 7.40B
-19.9%
Gross Margin
43.64%
N/A
Market Cap
$3.86B
N/A
Market Cap/Employee
$435.66K
N/A
Employees
8,867
N/A
Net Income
ZAR 1.46B
-36.3%
EBITDA
ZAR 4.04B
-22.6%
Quarterly Fundamentals
Total Cash
ZAR 5.58B
-51.9%
Total Debt
ZAR 32.72B
-9.4%
Accounts Receivable
ZAR 10.07B
-19.8%
Inventory
ZAR 15.35B
-19.0%
Long Term Debt
ZAR 29.14B
+18.8%
Short Term Debt
ZAR 3.58B
-69.1%
Return on Assets
-1.56%
N/A
Return on Invested Capital
5.49%
N/A
Free Cash Flow
ZAR 2.43B
+714.4%
Operating Cash Flow
ZAR 3.55B
+45.7%